Can Mayor Mamdani Turn Climate Action Into an Affordability Win for NYC? – State of the Planet Below-average temperatures and gusty winds did not deter tens of thousands of people from gathering in lower Manhattan last week to witness Zohran Mamdani take an oath to become New York City’s next mayor. Mayor Zohran Mamdani. Credit: Karamccurdy via Wikimedia Commons “Beginning today, we will govern expansively and audaciously,” Mamdani said during his inauguration speech. “We may not always succeed, but never will we be accused of lacking […] Written by Guest January 11, 2026January 11, 2026 Saving Bookmark this article Bookmarked
The biggest biotech funding rounds in December 2025 The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in December 2025 across private and public funding types. In this article, we break down last month’s private and public fundraising activity, looking at the largest rounds in more detail. Private biotech funding rounds in December 2025 First, let’s take […] Written by Willow Shah-Neville January 10, 2026January 10, 2026 Saving Bookmark this article Bookmarked
Can Mayor Mamdani Turn Climate Action Into an Affordability Win for NYC? – State of the Planet Below-average temperatures and gusty winds did not deter tens of thousands of people from gathering in lower Manhattan last week to witness Zohran Mamdani take an oath to become New York City’s next mayor. Mayor Zohran Mamdani. Credit: Karamccurdy via Wikimedia Commons “Beginning today, we will govern expansively and audaciously,” Mamdani said during his inauguration speech. “We may not always succeed, but never will we be accused of lacking […] Written by Guest January 11, 2026January 11, 2026 Saving Bookmark this article Bookmarked
The biggest biotech funding rounds in December 2025 The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in December 2025 across private and public funding types. In this article, we break down last month’s private and public fundraising activity, looking at the largest rounds in more detail. Private biotech funding rounds in December 2025 First, let’s take […] Written by Willow Shah-Neville January 10, 2026January 10, 2026 Saving Bookmark this article Bookmarked
The 4x rule: Why some people’s DNA is more unstable than others A large scale genetic analysis of more than 900,000 people has revealed that specific regions of DNA become increasingly unstable over time. These regions are made up of very short sequences that repeat again and again, and the study shows that they tend to grow longer as people age. Researchers also found that common inherited […] Written by Admin January 10, 2026January 10, 2026 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked
